Erratum to Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease [J Antimicrob Chemother 2016; 71: 718-726]
Academic Article
Publication Date:
2016
Short description:
Erratum to Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease [J Antimicrob Chemother 2016; 71: 718-726] / Cornely, O. A.; Duarte, R. F.; Haider, S.; Chandrasekar, P.; Helfgott, D.; Jimenez, J. L.; Candoni, A.; Raad, I.; Laverdiere, M.; Langston, A.; Kartsonis, N.; Van Iersel, M.; Connelly, N.; Waskin, H.. - In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. - ISSN 0305-7453. - 71:6(2016), pp. 1747-1747. [10.1093/jac/dkw079]
Iris type:
Articolo su rivista
List of contributors:
Cornely, O. A.; Duarte, R. F.; Haider, S.; Chandrasekar, P.; Helfgott, D.; Jimenez, J. L.; Candoni, A.; Raad, I.; Laverdiere, M.; Langston, A.; Kartsonis, N.; Van Iersel, M.; Connelly, N.; Waskin, H.
Published in: